JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.
The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus meeting of the Liver Cancer Study Group of Japan. Three important items have been updated: the surveillance and diagnostic algorithm, the treatment algorithm, and the definition of transarterial chemoembolization (TACE) failure/refractoriness. The most important update to the diagnostic algorithm is the inclusion of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a first line surveillance/diagnostic tool. Another significant update concerns removal of the term "lipiodol" from the definition of TACE failure/refractoriness.
['Kudo|Masatoshi|M|', 'Matsui|Osamu|O|', 'Izumi|Namiki|N|', 'Iijima|Hiroko|H|', 'Kadoya|Masumi|M|', 'Imai|Yasuharu|Y|', 'Okusaka|Takuji|T|', 'Miyayama|Shiro|S|', 'Tsuchiya|Kaoru|K|', 'Ueshima|Kazuomi|K|', 'Hiraoka|Atsushi|A|', 'Ikeda|Masafumi|M|', 'Ogasawara|Sadahisa|S|', 'Yamashita|Tatsuya|T|', 'Minami|Tetsuya|T|', 'Yamakado|Koichiro|K|', '|||']
Clinical practice guidelines Hepatocellular carcinoma Liver Cancer Study Group of Japan Japan Society of Hepatology Definition of transarterial chemoembolization failure